Fall 2020 is seeing continued global spread of COVID-19 with uncertainties about the effects of school reopenings on transmission and the prospects for dual COVID-19 and influenza outbreaks heading into colder months. Vaccine trials are heading into phases 2 and 3, and the FDA’s earlier-year reliance on emergency use authorizations (EUAs) under perceived political pressures to deliver pandemic solutions is raising concerns about the integrity of approval processes for vaccines potentially offered to millions of otherwise healthy people.

Browse the JAMA Network COVID-19 collection below, including Q&A's with NIAID's Anthony Fauci, an interactive map of the outbreak courtesy of The Johns Hopkins Center for Systems Science and Engineering, and past publications on vaccine development, infection control, and public health preparedness.